NCR1 and neoplasm: KRAS mutated tumors had a significantly lower infiltration of NKp46+ NKT cells in the tumor and stromal compartments, and higher infiltration of NK cells, CD56+ NKT cells and CD68+ macrophages in the stromal compartment.